Interesting Questions, Facts and Information
- There are a total of 10 general entries.
Interesting Questions, Facts, and Information
Propulsid. Propulsid was removed from the market as of July 14th due to the risk of arrhythmia when used in certain patients or combined with other drugs.
Toenail fungus. Penlac is the first FDA approved topical antifungal for the treatment of toenail fungus.
HIV. Sustiva is used to treat HIV and is associated with significant side effects including drowsiness, dizziness, vivid dreams, etc. due to the drugs ability to penetrate the central nervous system.
Influenza. Relenza is a 'diskhaler' used to treat the flu. However, the drug must be started within the first 48 hours of symptoms to provide a full benefit.
|What is the name of the new blood glucose monitor which allows patients to use a blood sample from the arm rather than the fingertip?||Prescription Drugs in the US
Freestyle. The Freestyle is a new monitor which allows patients to use a blood sample from the forearm. The sample required is much smaller than that of the traditional machines and the price is comparable.
Severe PMS. Sarafem is mareketed by Lilly and is essentially the same as Prozac but packaged in 7 day blister packs and taken only during the menstrual cycle or the week or two preceeding it depending on symptoms.
Blocking the absorption of fat. Xenical is a fat blocker which may also help to lower cholesterol and blood pressure. However, side effects include flatulence and oily stools which are orange in color. The patient may also lose the ability to control bowel function, especially if dietary fat intake is not reduced.
Alzheimer's. Exelon is a cholinesterase inhibitor similar to Aricept. These drugs may delay the need for nursing home placement in individuals with mild to moderate symptoms of Alzheimer's disease.
Osteoarthritis. Mobic is a new non-steroidal anti-inflammatory (NSAID) which causes less stomach upset than more common NSAIDS such as naproxen, ibuprofen, etc.
Antibiotic. Zyvox is a new antibiotic indicated for the treatment of vancomycin resistant infections. These infections are very severe and do not respond to other antibiotics. Vancomycin has been reserved for infections not responding to other antibiotics, however mutations have made some bacteria resistant to this last resort drug prompting research into new antibiotics such as Zyvox.